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Abstract
The articles in this forum issue describe various aspects of the folding of disulfide-rich proteins. They include
review articles using proteins such as bovine pancreatic trypsin inhibitor as models to highlight the range of
folding pathways seen in disulfide-rich proteins, along with a detailed analysis of the methods used to study
them. Following two comprehensive reviews on the methods and applications of protein folding, three original
articles in this issue focus on two specific classes of disulfide-rich proteins that have applications in drug design
and development, namely cyclotides and conotoxins. Cyclotides are head-to-tail cyclic and disulfide-rich pro-
teins from plants and function as a defense against insect attack. Conotoxins are the disulfide-rich components of
the venom of marine cone snails that is used to capture prey. These research articles report on factors that
modulate protein folding pathways in these molecules and determine the outcomes of protein folding, that is,
yield and heterogeneity of products. Finally, the issue concludes with a comprehensive review on a different
type of disulfide bond, namely those that have a functional rather than structural role in proteins, with a
particular focus on allosteric disulfide bonds that modify protein function. Antioxid. Redox Signal. 14, 61–64.
Introduction
Disulfide bonds play a unique and important role instabilizing the structures of a diverse range of proteins.
This forum issue presents a series of articles that examine how
the final folded structures of disulfide-rich proteins are
formed. The main emphasis of these articles is on the folding
pathways, rather than on the final structures themselves. The
general area of protein folding is of course a huge field (5, 15,
16, 21, 22) that has blossomed since the pioneering work of
Anfinsen (3), which first suggested that the information nec-
essary to define the final folded shape of a protein was en-
coded within its primary sequence. Our focus here is on
disulfide-rich proteins, which, in addition to being subject to
the conformational folding processes that occur in all proteins,
are subject to the additional process of oxidative folding to
correctly link pairs of cystine residues to form specific dis-
ulfide bonds. In a broad sense, conformational folding and
oxidative folding can be regarded as analog and digital pro-
cesses, respectively, with the former involving, in many cases,
a continuum of intermediate states, whereas the latter is
punctuated by more specifically definable intermediates,
where individual disulfide bonds are either ‘‘on’’ or ‘‘off.’’ The
articles in this issue describe approaches to define these digital
states and structures of the corresponding intermediates.
Principles and Methods
The issue commences with two forum review articles that
provide an overview of the folding pathways of disulfide-rich
proteins. In the first article by Arolas and Ventura (6), the
protease inhibitor class of proteins is used to illustrate the
principles of folding of disulfide-rich proteins. Protease in-
hibitors are an excellent choice to illustrate these principles,
because these inhibitory proteins have a wide range of im-
portant biological functions, are generally small and hence
tractable to study, are typically cross-linked by multiple dis-
ulfide bonds, and indeed are among the most widely studied
classes of proteins from a folding perspective. Their natural
functions range from regulatory roles for a variety of physi-
ological processes, to host defense roles. The authors describe
the great diversity of folding pathways that are observed in
this family of proteins, with the pathways differing in the
heterogeneity and native disulfide content of their interme-
diates. This diversity is nicely illustrated by the study of two
extreme examples of the folding process, for bovine pancre-
atic trypsin inhibitor and hirudin, which fold via few native
intermediates and through heterogeneous scrambled isomers,
respectively. The authors also describe other protease inhibi-
tors that fold through intermediate types of pathways, such as
the leech carboxypeptidase inhibitor. The lessons learnt in
these single-domain proteins is then extended to studies of
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two-domain protease inhibitors, with examples including
cases in which the two domains fold autonomously, or other
cases in which the folding is synergistic, with one domain
assisting in the folding of the other.
The authors also describe several recent studies in which,
for the first time, the structures of actual intermediates on the
folding pathway have been determined. In most early studies
of the folding of disulfide-rich proteins, there was little
quantitative information available on the structures of these
intermediates. Their structures were typically deduced from
artificially mutated constructs, or predicted, rather than being
experimentally determined to high resolution, but with ex-
perimental structures of actual intermediates now becoming
available, folding pathways can be described much more
precisely.
In the second article in this issue, Chang (9) uses two ex-
ample proteins, bovine pancreatic trypsin inhibitor and tick
anticoagulant protein, to describe methodological aspects of
the study of oxidative protein folding. These methods are
placed in context by first providing an overview of protein
folding in general, including a description of conformational
folding and oxidative folding. There are currently two fa-
vored models of conformational folding. The framework
model proposes that secondary structures form first during
the early stages of folding and this is followed by the packing
of these preformed secondary structure motifs to form the
native tertiary structure. In contrast, the hydrophobic collapse
model involves a rapid hydrophobic collapse as the major
driving force for folding, which is followed by conformational
searching within a confined volume to reach the native
structure. The article focuses mainly on methods to study
disulfide-rich proteins and describes two distinct approaches:
one in which a denaturant is used together with a reducing
agent to provide the starting material for oxidative folding,
and another involving a denaturant and thiol catalyst. The
latter, referred to as the scrambled folding method, leads to a
mixture of oxidized scrambled isomers that are amenable to
fractionation, isolation, and further structural analysis. The
folding pathways measured by either method are defined by
the heterogeneity, structures, and kinetic properties of the
intermediates identified. One of the main conclusions of the
article is that one of the underlying causes of the diversity of
folding pathways is the relative stability of protein sub-
domains.
New Experimental Results in the Folding of Cyclic
Disulfide-Rich Proteins
Following these two introductory overview articles are a
series of original research articles that examine various as-
pects of the folding of disulfide-rich proteins. The focus is on
two specific classes of naturally occurring peptides in these
studies, namely cyclotides and conotoxins. Cyclotides are
plant-derived disulfide-rich miniproteins of about 30 amino
acids in size that were discoveredmore than a decade ago (13)
and have the distinguishing feature of a head-to-tail cyclized
backbone and a cystine knot arrangement of their three con-
served disulfide bonds. This makes them exceptionally stable
(11), a feature that has led to suggestions of their use as tem-
plates in peptide-based drug design (12, 23, 24). In the cystine
knot motif, two disulfide bonds and their connecting back-
bone segment form an embedded ring in the structure that is
penetrated by the third disulfide bond. Such a topologically
compact and complex motif makes them particularly inter-
estingmolecules that can be used to study oxidative folding to
answer the question—how does the knot form (17)?
Cyclotides occur in a wide range of plants, including spe-
cies from the Rubiaceae (coffee) andViolaceae (violet) families
and are thought to play a role in plant defense, a suggestion
consistent with the finding that they are potent insecticidal
agents (8). However, our focus in this issue is not on their
natural functions but on the way in which they achieve their
final folded state. The reason for this focus is there is a great
deal of interest in developing ways to chemically synthesize
cyclotides so that they can be optimized for pharmaceutical or
agricultural applications (14). To optimize their chemical
synthesis, it is important to understand the folding pathways
that lead to the cystine knot motif.
The team led by Ulf Go¨ransson at Uppsala University de-
scribe in their article (1) new approaches to understand and
optimize the oxidative folding of cyclotides. They report that
the folding of selected cyclotides is heavily influenced by the
concentration of redox reagents, with the folding rate and
final yield of the native isomer greatly enhanced by high
concentrations of glutathione. The addition of a hydrophobic
solvent such as isopropanol to the buffer also accelerated the
folding rates and, in some cases, altered the folding pathway.
The hydrophobic solvent appears to help because cyclotides
tend to have a patch of surface-exposed hydrophobic residues
in their native structures. The elucidation of the factors that
influence the folding of cyclotides should greatly facilitate
chemical methods for producing native cyclotides or modi-
fied derivatives as stable peptide-based pharmaceutical or
agricultural agents.
Conotoxins are disulfide-rich peptides from the venom of
marine snails of the genus Conus (29). These snails use their
venom for the capture of prey, which includes fish, worms,
and other snails. Conotoxins typically target a wide range of
receptors, including ion channels and transporters, and aside
from their use in prey capture they have attracted the interest
of pharmaceutical chemists as leads in drug design (2, 20, 25,
27). As with the cyclotides, there is interest in synthetically
modifying conotoxins to exploit their potential in drug de-
sign. As they are disulfide-rich, the challenge has been to
discover ways of properly folding them. Further, there has
been interest in attempting to stabilize their structures, to
improve their biopharmaceutical properties. Recent efforts
have focused on developing methods for cyclizing conotoxins
to make them more cyclotide-like, thus engendering them
with high stabilities (10).
Two original research articles in this issue focus on the
folding of cyclized derivatives of one particular conotoxin,
namely AuIB. This molecule targets specific subtypes of the
nicotinic acetylcholine receptor. Lovelace et al. (26) describe
the role of linkers of four to seven amino acid residues in
joining the N and C termini of AuIB to make cyclized deriv-
atives. Peptide cyclization was achieved using an in-
tramolecular version of a native chemical ligation reaction
(19), as had earlier been applied to the synthesis of cyclotides
(18, 28). The linker length strongly influenced the relative
proportions of different disulfide isomers produced in the
oxidative folding reaction. In a complementary study, Ar-
mishaw and colleagues (4) examined a range of cyclized AuIB
derivatives that included shorter linkers and were again fo-
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cused on folding outcomes. They found that the linker had an
important influence on folding outcome, and in particular,
shorter linkers favored the formation of a nonnative ‘‘ribbon’’
disulfide connectivity (CysI-CysIV and CysII-CysIII), com-
pared with the native, globular form (CysI-CysIII and CysII-
CysIV). Overall, these studies have provided new insights into
the factors controlling the oxidative folding of cyclized con-
otoxin derivatives and new knowledge underpinning their
applications in drug design.
Another Side of the Coin—
A Functional Role for Disulfide Bonds
In the final article of this issue, the focus turns from the
structural role of disulfide bonds to the functional role played
by certain disulfide bonds. The two types of functional roles
identified for disulfide bonds are as catalytic moieties or al-
losteric disulfides. Catalytic disulfides=dithiols transfer elec-
trons between proteins, whereas allosteric disulfide bonds
modulate the functions of the proteins in which they reside
when they undergo a redox change. Azimi et al. (7) describe
the five known examples of allosteric disulfide bonds and
speculate on the existence of several others. They describe
how these disulfide bonds control the activity of the respec-
tive proteins. A common feature of all of the allosteric bonds
identified so far is that they link b-strands or b-loops.
Future Trends
Some of the important findings that have become apparent
from the articles in this issue include an understanding of the
factors affecting the diversity of folding pathways, a trend
toward quantitative analysis of the structures of folding in-
termediates, the ability to modulate folding outcomes via cy-
clization reactions, and an increasing recognition of the
importance of allosteric disulfide bonds in modulating pro-
tein function. The capability to determine the structures of
individual disulfide-bonded intermediates has arisen because
of improved biophysical modalities, including, in particular,
nuclear magnetic resonance and mass spectrometry. It seems
clear that such studies will continue to provide a stimulus for
more precisely defining protein folding pathways. With this
increased knowledge of folding pathways will come im-
proved ways of designing disulfide-rich peptides for phar-
maceutical applications. Cyclic disulfide-rich peptides appear
to be particularly suitable targets for such studies, as illus-
trated by the examples of cyclotides and cyclized conotoxins
reported in this issue. I thank all of the contributing authors
for their timely and authoritative articles and hope that
readers will find the issue informative and useful.
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